Fidelity Select Portfolios · net assets $6.75B · 156 holdings as of August 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 97.9% · EP: 1.5% · STIV: 0.4% · DBT: 0.1%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $37.2M | $47.3M | $35.4M |
| Reinvestment | $0 | $72.7 | $0 |
| Redemptions | $101M | $75.3M | $81.2M |
| Net realized gain (non-derivative) | $143M | $128M | $97.7M |
| Net unrealized appreciation (non-derivative) | $506M | $-169M | $399M |
The three months of the reporting period, as filed; month 3 ends August 31, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Eli Lilly And Co EC | $480M | 7.11% |
| Thermo Fisher Scientific Inc EC | $450M | 6.67% |
| Danaher Corp EC | $448M | 6.64% |
| Unitedhealth Group Inc EC | $218M | 3.23% |
| Johnson And Johnson EC | $207M | 3.07% |
| Abbvie Inc EC | $191M | 2.83% |
| Natera Inc EC | $187M | 2.77% |
| Merck And Co Inc EC | $174M | 2.58% |
| West Pharmaceutical Svcs Inc EC | $172M | 2.55% |
| Argenx Se EC | $155M | 2.29% |
| Alnylam Pharmaceuticals Inc EC | $132M | 1.96% |
| Ascendis Pharma A/s EC | $132M | 1.95% |
| Agilent Technologies Inc EC | $123M | 1.82% |
| Waters Corp EC | $116M | 1.72% |
| Viatris Inc EC | $116M | 1.71% |
| Moderna Inc EC | $112M | 1.66% |
| Revolution Medicines Inc EC | $104M | 1.54% |
| Repligen Corp EC | $103M | 1.53% |
| 10x Genomics Inc EC | $102M | 1.51% |
| Jazz Pharmaceuticals PLC EC | $100M | 1.49% |
| Guardant Health Inc EC | $93M | 1.38% |
| Illumina Inc EC | $85.5M | 1.27% |
| Ucb Sa EC | $82M | 1.22% |
| Oruka Therapeutics Inc EC | $81.5M | 1.21% |
| Vaxcyte Inc EC | $77.7M | 1.15% |
| Boston Scientific Corp EC | $77.3M | 1.14% |
| Kiniksa Pharmaceuticals International PLC EC | $76.3M | 1.13% |
| Enliven Therapeutics Inc EC | $74.1M | 1.10% |
| Royalty Pharma PLC EC | $73.7M | 1.09% |
| Gilead Sciences Inc EC | $70.2M | 1.04% |
| Sartorius Stedim Biotech EC | $64.9M | 0.96% |
| Cogent Biosciences Inc EC | $64.8M | 0.96% |
| Lifestance Health Group Inc EC | $61.8M | 0.92% |
| Spyre Therapeutics Inc EC | $61.4M | 0.91% |
| Brightspring Health Services Inc EC | $58.4M | 0.87% |
| Kymera Therapeutics Inc EC | $57M | 0.84% |
| Amylyx Pharmaceuticals Inc EC | $54M | 0.80% |
| Bruker Corp EC | $53.2M | 0.79% |
| Xenon Pharmaceuticals Inc EC | $51.8M | 0.77% |
| Insmed Inc EC | $51.8M | 0.77% |
| Praxis Precision Medicines Inc. EC | $49M | 0.73% |
| Caris Life Sciences Inc EC | $48.1M | 0.71% |
| Heartflow Inc EC | $47.9M | 0.71% |
| Dianthus Therapeutics Inc EC | $47.5M | 0.70% |
| Legend Biotech Corp EC | $47.4M | 0.70% |
| Roivant Sciences Ltd EC | $44.3M | 0.66% |
| Twist Bioscience Corp EC | $44.2M | 0.65% |
| Biogen Inc EC | $43.3M | 0.64% |
| Veracyte Inc EC | $43.2M | 0.64% |
| Mbx Biosciences Inc EC | $41.9M | 0.62% |
| Nextcure Inc EC | $39.7M | 0.59% |
| Relay Therapeutics Inc EC | $38.2M | 0.57% |
| Zenas Biopharma Inc EC | $34.9M | 0.52% |
| Viridian Therapeutics Inc EC | $34.7M | 0.51% |
| Cg Oncology Inc EC | $34.6M | 0.51% |
| Beone Medicines Ltd EC | $32.4M | 0.48% |
| 10x Genomics Inc EC | $31.2M | 0.46% |
| Cvs Health Corp EC | $31M | 0.46% |
| Mineralys Therapeutics Inc EC | $30.3M | 0.45% |
| Disc Medicine Inc EC | $29.9M | 0.44% |
Showing top 60 of 156 holdings.
Loading...
